{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:01:11Z","timestamp":1786993271257,"version":"build-2736575974"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jpsychires.2023.03.045","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T08:35:50Z","timestamp":1681202150000},"page":"44-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Molecular brain differences and cannabis involvement: A systematic review of positron emission tomography studies"],"prefix":"10.1016","volume":"162","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-0413","authenticated-orcid":false,"given":"Hui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max M.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Farncombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Noseworthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"MacKillop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.045_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.brainresrev.2007.07.014","article-title":"Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective","volume":"56","author":"Alcaro","year":"2007","journal-title":"Brain Res. Rev."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.045_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1097\/00004647-199609000-00005","article-title":"Sample size and statistical power in [15O]H2O studies of human cognition","volume":"16","author":"Andreasen","year":"1996","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.045_bib3","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/archneur.1993.00540050026010","article-title":"Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride","volume":"50","author":"Antonini","year":"1993","journal-title":"Arch. Neurol."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.045_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/npr2.12084","article-title":"PET technology for drug development in psychiatry","volume":"40","author":"Arakawa","year":"2020","journal-title":"Neuropsychopharmacology Reports"},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.045_bib5","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamapsychiatry.2017.0135","article-title":"Association of stimulant use with dopaminergic alterations in users of cocaine, amphetamine, or methamphetamine: a systematic review and meta-analysis","volume":"74","author":"Ashok","year":"2017","journal-title":"JAMA Psychiatr."},{"issue":"7629","key":"10.1016\/j.jpsychires.2023.03.045_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nature20153","article-title":"The effects of Delta(9)-tetrahydrocannabinol on the dopamine system","volume":"539","author":"Bloomfield","year":"2016","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.03.045_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.biopsych.2013.05.027","article-title":"Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms","volume":"75","author":"Bloomfield","year":"2014","journal-title":"Biol. Psychiatr."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.03.045_bib8","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s00213-014-3523-4","article-title":"The link between dopamine function and apathy in cannabis users: an [18F]-DOPA PET imaging study","volume":"231","author":"Bloomfield","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2023.03.045_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.pharmthera.2018.10.006","article-title":"The neuropsychopharmacology of cannabis: a review of human imaging studies","volume":"195","author":"Bloomfield","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.03.045_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.biopsych.2016.04.012","article-title":"Fatty acid amide hydrolase binding in brain of cannabis users: imaging with the novel radiotracer [(11)C]CURB","volume":"80","author":"Boileau","year":"2016","journal-title":"Biol. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.045_bib11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.neuroimage.2005.02.012","article-title":"Neural substrates of faulty decision-making in abstinent marijuana users","volume":"26","author":"Bolla","year":"2005","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.045_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/npp.2017.206","article-title":"CB1 receptor signaling in the brain: extracting specificity from ubiquity","volume":"43","author":"Busquets-Garcia","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.045_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"Button","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.045_bib14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/adb.12116","article-title":"[18F]MK-9470 PET measurement of cannabinoid CB1 receptor availability in chronic cannabis users","volume":"20","author":"Ceccarini","year":"2015","journal-title":"Addiction Biol."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.045_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00406-019-00983-5","article-title":"New trends in cannabis potency in USA and Europe during the last decade (2008-2017)","volume":"269","author":"Chandra","year":"2019","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"5\u20136","key":"10.1016\/j.jpsychires.2023.03.045_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00008877-200209000-00018","article-title":"SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats","volume":"13","author":"Cohen","year":"2002","journal-title":"Behav. Pharmacol."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.045_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-021-00247-4","article-title":"Cannabis use and cannabis use disorder","volume":"7","author":"Connor","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.045_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/09540260902782752","article-title":"Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence","volume":"21","author":"Cooper","year":"2009","journal-title":"Int. Rev. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2023.03.045_bib19","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1038\/s41380-020-00891-4","article-title":"Preliminary in vivo evidence of lower hippocampal synaptic density in cannabis use disorder","volume":"26","author":"D'Souza","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.03.045_bib20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/jamapsychiatry.2019.2516","article-title":"In vivo imaging of translocator protein in long-term cannabis users","volume":"76","author":"Da Silva","year":"2019","journal-title":"JAMA Psychiatr."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.03.045_bib21","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/s41386-018-0287-2","article-title":"Methylphenidate's effects on thalamic metabolism and functional connectivity in cannabis abusers and healthy controls","volume":"44","author":"Demiral","year":"2019","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.045_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.acra.2011.10.008","article-title":"Design considerations for using PET as a response measure in single site and multicenter clinical trials","volume":"19","author":"Doot","year":"2012","journal-title":"Acad. Radiol."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.03.045_bib23","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neuroimage.2004.07.032","article-title":"Abnormal brain activity in prefrontal brain regions in abstinent marijuana users","volume":"23","author":"Eldreth","year":"2004","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.045_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1520\/JFS14636J","article-title":"Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980-1997","volume":"45","author":"ElSohly","year":"2000","journal-title":"J. Forensic Sci."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.045_bib25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41593-020-0611-0","article-title":"Deconstructing the neurobiology of cannabis use disorder","volume":"23","author":"Ferland","year":"2020","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.03.045_bib26","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/npp.2012.91","article-title":"Chronic Delta(9)-tetrahydrocannabinol exposure induces a sensitization of dopamine D(2)\/(3) receptors in the mesoaccumbens and nigrostriatal systems","volume":"37","author":"Ginovart","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"10.1016\/j.jpsychires.2023.03.045_bib27","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"J. Clin. Epidemiol."},{"issue":"12","key":"10.1016\/j.jpsychires.2023.03.045_bib28","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1039\/C6NP00074F","article-title":"Phytocannabinoids: a unified critical inventory","volume":"33","author":"Hanus","year":"2016","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.jpsychires.2023.03.045_bib29","series-title":"Handbook of Neurochemistry and Molecular Neurobiology: Neurotransmitter Systems","first-page":"149","article-title":"Dopamine and the dopaminergic systems of the brain","author":"Harsing","year":"2008"},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.045_bib30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/npp.2017.198","article-title":"US epidemiology of cannabis use and associated problems","volume":"43","author":"Hasin","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.03.045_bib31","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the national epidemiologic survey on alcohol and related conditions-III","volume":"173","author":"Hasin","year":"2016","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.jpsychires.2023.03.045_bib32","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.045_bib33","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.03.045_bib34","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.03.045_bib35","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1046\/j.1471-4159.2003.01576.x","article-title":"Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens","volume":"84","author":"Hungund","year":"2003","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.045_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12872","article-title":"Fatty acid amide hydrolase is lower in young cannabis users","volume":"26","author":"Jacobson","year":"2021","journal-title":"Addiction Biol."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.045_bib37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1152\/physrev.00049.2010","article-title":"A molecular imaging primer: modalities, imaging agents, and applications","volume":"92","author":"James","year":"2012","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.jpsychires.2023.03.045_bib38","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.addbeh.2018.11.005","article-title":"Changes in the prevalence and correlates of cocaine use and cocaine use disorder in the United States, 2001-2002 and 2012-2013","volume":"90","author":"Kerridge","year":"2019","journal-title":"Addict. Behav."},{"issue":"17","key":"10.1016\/j.jpsychires.2023.03.045_bib39","doi-asserted-by":"crossref","first-page":"9566","DOI":"10.1073\/pnas.1921475117","article-title":"Dynamic coupling of whole-brain neuronal and neurotransmitter systems","volume":"117","author":"Kringelbach","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpsychires.2023.03.045_bib40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.neuroimage.2018.10.013","article-title":"Sex difference in brain CB1 receptor availability in man","volume":"184","author":"Laurikainen","year":"2019","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.jpsychires.2023.03.045_bib41","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.104.077974","article-title":"Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence","volume":"312","author":"Le Foll","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.045_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamapsychiatry.2017.0113","article-title":"Changes in US lifetime heroin use and heroin use disorder: prevalence from the 2001-2002 to 2012-2013 national epidemiologic survey on alcohol and related conditions","volume":"74","author":"Martins","year":"2017","journal-title":"JAMA Psychiatr."},{"issue":"11","key":"10.1016\/j.jpsychires.2023.03.045_bib43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrn3811","article-title":"Early phytocannabinoid chemistry to endocannabinoids and beyond","volume":"15","author":"Mechoulam","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jpsychires.2023.03.045_bib44","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.03.045_bib45","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/npp.2012.232","article-title":"Dopamine response to psychosocial stress in chronic cannabis users: a PET study with [11C]-+-PHNO","volume":"38","author":"Mizrahi","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.jpsychires.2023.03.045_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.jpsychires.2023.03.045_bib47","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1192\/bjp.bp.112.121178","article-title":"Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms","volume":"202","author":"Morgan","year":"2013","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpsychires.2023.03.045_bib48","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/jcbfm.2015.46","article-title":"Imaging the cannabinoid CB1 receptor in humans with [11C] OMAR: assessment of kinetic analysis methods, test\u2013retest reproducibility, and gender differences","volume":"35","author":"Normandin","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"2","key":"10.1016\/j.jpsychires.2023.03.045_bib49","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1037\/bul0000181","article-title":"Functional and structural neuroimaging studies of delayed reward discounting in addiction: a systematic review","volume":"145","author":"Owens","year":"2019","journal-title":"Psychol. Bull."},{"issue":"16","key":"10.1016\/j.jpsychires.2023.03.045_bib50","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","article-title":"Positron emission tomography provides molecular imaging of biological processes","volume":"97","author":"Phelps","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.03.045_bib51","first-page":"210","article-title":"Application of annihilation coincidence detection to transaxial reconstruction tomography","volume":"16","author":"Phelps","year":"1975","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.jpsychires.2023.03.045_bib52","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1176\/ajp.153.6.850","article-title":"Reviewing DSM-IV","volume":"153","author":"Pincus","year":"1996","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.03.045_bib53","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.semnuclmed.2015.03.008","article-title":"Pitfalls and limitations of PET\/CT in brain imaging","volume":"45","author":"Salmon","year":"2015","journal-title":"Semin. Nucl. Med."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.03.045_bib54","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1359-6446(05)03412-4","article-title":"Imaging addiction with PET: is insight in sight?","volume":"10","author":"Schiffer","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.jpsychires.2023.03.045_bib55","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00259-003-1299-6","article-title":"PET\/CT: a new imaging technology in nuclear medicine","volume":"30","author":"Sch\u00f6der","year":"2003","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.03.045_bib56","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-008-1075-1","article-title":"Cerebral glucose metabolism and D2\/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography","volume":"197","author":"Sevy","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2023.03.045_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neuropharm.2017.05.031","article-title":"The endocannabinoid system as a target for addiction treatment: trials and tribulations","volume":"124","author":"Sloan","year":"2017","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.03.045_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13061","article-title":"Brain imaging of cannabinoid type I (CB1) receptors in women with cannabis use disorder and male and female healthy controls","volume":"26","author":"Spindle","year":"2021","journal-title":"Addiction Biol."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.03.045_bib59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000521103","article-title":"Extrastriatal dopamine D2\/3 receptor availability in alcohol use disorder and individuals at high risk","volume":"81","author":"Spitta","year":"2022","journal-title":"Neuropsychobiology"},{"issue":"16","key":"10.1016\/j.jpsychires.2023.03.045_bib60","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.febslet.2007.05.037","article-title":"Inhibition of microglial fatty acid amide hydrolase modulates LPS stimulated release of inflammatory mediators","volume":"581","author":"Tham","year":"2007","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.03.045_bib61","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1002\/hbm.22834","article-title":"Balanced modulation of striatal activation from D2\/D3 receptors in caudate and ventral striatum: disruption in cannabis abusers","volume":"36","author":"Tomasi","year":"2015","journal-title":"Hum. Brain Mapp."},{"issue":"8","key":"10.1016\/j.jpsychires.2023.03.045_bib62","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.biopsych.2011.12.018","article-title":"Dopamine release in chronic cannabis users: a [11c]raclopride positron emission tomography study","volume":"71","author":"Urban","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.045_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/mp.2016.21","article-title":"Deficits in striatal dopamine release in cannabis dependence","volume":"22","author":"van de Giessen","year":"2017","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2023.03.045_bib64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0925-4927(96)02817-X","article-title":"Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication","volume":"67","author":"Volkow","year":"1996","journal-title":"Psychiatr. Res."},{"issue":"30","key":"10.1016\/j.jpsychires.2023.03.045_bib65","doi-asserted-by":"crossref","first-page":"E3149","DOI":"10.1073\/pnas.1411228111","article-title":"Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity","volume":"111","author":"Volkow","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.jpsychires.2023.03.045_bib66","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1038\/npp.2016.67","article-title":"Cannabis abusers show hypofrontality and blunted brain responses to a stimulant challenge in females but not in males","volume":"41","author":"Wiers","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.jpsychires.2023.03.045_bib67","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2165\/00003495-200060060-00005","article-title":"Cannabinoids in clinical practice","volume":"60","author":"Williamson","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.jpsychires.2023.03.045_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/B978-0-444-64123-6.00011-4","article-title":"Sex and the dopaminergic system: insights from addiction studies","volume":"175","author":"Woodcock","year":"2020","journal-title":"Handb. Clin. Neurol."},{"issue":"9","key":"10.1016\/j.jpsychires.2023.03.045_bib69","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nn.2874","article-title":"Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice","volume":"14","author":"Xi","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jpsychires.2023.03.045_bib70","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jpsychires.2022.06.037","article-title":"Aberrant hippocampal shape development in young adults with heavy cannabis use: evidence from a longitudinal study","volume":"152","author":"Xu","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2023.03.045_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2022.02.012","article-title":"Altered structural and functional connectivity of salience network in patients with classic trigeminal neuralgia","author":"Xu","year":"2022","journal-title":"J. Pain"},{"issue":"5\u20136","key":"10.1016\/j.jpsychires.2023.03.045_bib72","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1089\/neu.2021.0426","article-title":"Restoration of aberrant shape of caudate subregions associated with cognitive function improvement in mild traumatic brain injury","volume":"39","author":"Xu","year":"2022","journal-title":"J. Neurotrauma"},{"issue":"15","key":"10.1016\/j.jpsychires.2023.03.045_bib73","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27154961","article-title":"Neuroprotection of cannabidiol, its synthetic derivatives and combination preparations against microglia-mediated neuroinflammation in neurological disorders","volume":"27","author":"Yousaf","year":"2022","journal-title":"Molecules"},{"issue":"18","key":"10.1016\/j.jpsychires.2023.03.045_bib74","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1523\/JNEUROSCI.3554-05.2006","article-title":"Two brain sites for cannabinoid reward","volume":"26","author":"Zangen","year":"2006","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.03.045_bib75","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11481-018-9782-9","article-title":"Cannabis addiction and the brain: a review","volume":"13","author":"Zehra","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2023.03.045_bib76","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s11481-018-9782-9","article-title":"Cannabis addiction and the brain: a review","volume":"13","author":"Zehra","year":"2018","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"3","key":"10.1016\/j.jpsychires.2023.03.045_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030833","article-title":"Cannabinoid receptors and the endocannabinoid system: signaling and function in the central nervous system","volume":"19","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623001644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395623001644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T11:34:38Z","timestamp":1758368078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395623001644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":77,"alternative-id":["S0022395623001644"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.03.045","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular brain differences and cannabis involvement: A systematic review of positron emission tomography studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2023.03.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}